[8]
Amasya, G.; Karavana, S.Y.; Şen, T.; Baloglu, E.; Tarimci, N. Bioadhesive and mechanical properties of triamcinolone ace-tonide buccal gels. Turk. J. Pharm. Sci., 2012, 9(1), 1-12.
[13]
Phadtare, D.; Phadtare, N.B.G.; Asawat, M. Hypromellose: A choice of polymer in extended release tablet formulation. World J. Pharm. Pharm. Sci., 2014, 3(9), 551-566.
[15]
Pfeiffer, D.F.; Powala, C. Methods of treating recurrent aphthous
stomatitis. U.S. Patent 20060252731A1 2006.
[17]
Wadhawan, R.; Sharma, S.; Solanki, G.; Vaishnav, R. Alterna-tive medicine for aphthous stomatitis: A review. Int. J. A A Case Rep., 2014, 1(1), 5-10.
[22]
Puri, N.; Gill, J.K.; Kaur, H.; Kaur, N.; Kaur, J. Recurrent aphthous stomatitis: Therapeutic management from topicals to systemics. J. Adv. Med. Dent. Sci. Res., 2015, 3(2), 165-170.
[23]
Yildirim, E.; Işik, M.M.; Jain, S.; Sezgin, A.; Karaer, O.; Karasu, T.R.; Yilmaz, K. Stable pharmaceutical combination containing
benzydamine. W.O. Patent 2016126217Al 2016.
[24]
Francese, F.; Olden, D. Pharmaceutical compositions containing a
benzydamine or its salt and an antimicrobial agent. E. Patent
0812193B1 2002.
[26]
Parashar, B.; Kabra, A.; Chandel, A. Formulation and evalua-tion of gel containing miconazole nitrate an antifungal agent. Int. J. Pharm. Res. Rev., 2013, 2(6), 18-28.
[27]
Suresh, P.K.; Manhar, S. Bioadhesive buccal gels impregnated with
fluconazole: formulation; in vitro and ex vivo characterization. J.
Appl. Pharm. Sci, 2014, 4(3), 015-019.
[29]
Karade, P.G.; Shah, R.R.; Chougule, D.D.; Bhise, S.B. Formu-lation and evaluation of celecoxib gel. J. Drug Deliv. Thera-peut., 2012, 2(3), 132-135.
[32]
Sharma, D.; Singh, R.; Garg, R. Development and validation of stability indicating UV spectro-photometric method for the estimation of benzydamine hydrochloride in bulk and in pharmaceutical dosage form: A novel analytical technique for conducting in-vitro quality control tests. Int. J. Pharm. Sci. Res., 2018, 9(2), 678-686.
[33]
Helal, D.A.; El-Rhman, D.A.B.D.; Abdel-Halim, S.A.; El-Nabarawi, M.A. Formulation and evaluation of fluconazole topical gel. Int. J. Pharm. Pharm. Sci., 2012, 4(5), 176-183.
[35]
Baibhav, J.; Singh, G.; Rana, A.C.; Saini, S.; Singla, V. Emulgel: A comprehensive review on the recent advances in topical drug delivery. Int. Res. J. Pharm., 2011, 2(1), 66-70.
[39]
Parmar, V.J.; Lumbhani, A.N. Formulation and development of thermoreversible mucoadhesive intranasal in situ Hydrogel by using a combination of polymers. Bullet. Pharm. Res., 2012, 2(3), 167-174.
[43]
Bhoyar, B.S.; Patil, A.T. Formulation and evaluation of oph-thalmic gel based on drug-polymer-polymer ternary interac-tion. Asian J. Pharm. Clin. Res., 2015, 8(3), 283-288.
[48]
Yadav, J.D.; Kunjwani, H.K.; Suryawanshi, S.S. Formulation and evaluation of thermosensitive in situ gel of salbutamol sulphate for nasal drug delivery system. Int. J. Pharm. Pharm. Sci., 2012, 4(4), 188-194.
[53]
Peddapalli, H.; Ganta, R.P.; Boggula, N. Formulation and evaluation of transdermal patches for antianxiety drug. Asian J. Pharm., 2018, 12(2), 127-136.
[56]
Pathan, I.B.; Mene, H.; Bairagi, S. Quality by design (QbD) approach to formulate in situ gelling system for nose to brain delivery of fluoxetine hydrochloride: Ex-vivo and In-vivo study. Ars Pharm., 2017, 58(3), 107-114.
[59]
Bose, P.S.C.; Reddy, P.S.; Ravi, V.; Sarita, D.; Kumar, T.M.P. Formulation and evaluation of sustained release floating tab-lets of diltiazem HCl using xanthan gum. Res. J. Pharm. Biol. Chem. Sci., 2011, 2, 319-328.